Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- Article
- Inhale, Exhale: The struggle of living with Severe Asthma and Severe Eosinophilic Asthma
Research Partnership
- Infographic
- Migraine market snapshot
Research Partnership
- Webinar
- Monitoring the impact of COVID-19 on the market access landscape
Research Partnership
- Live webinar from Singapore
- Digital #marcomms: How to evaluate and optimise marketing activities impacted by COVID-19
Research Partnership
- Guide
- UX research
Research Partnership
- Article: Why pharma must trust the science of behaviour
Research Partnership
